NCT05132569 Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis Status TERMINATED Phase PHASE3
NCT05045248 Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis Status COMPLETED Phase PHASE2
NCT05039190 Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients Status COMPLETED Phase PHASE3
NCT04951622 A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis Status RECRUITING Phase PHASE3
NCT04768465 Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis Status UNKNOWN Phase N/A
NCT04695379 Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection Status COMPLETED Phase N/A
NCT04678115 Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis Status COMPLETED Phase NA
NCT04590716 Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares Status COMPLETED Phase N/A
NCT04561557 Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System Status RECRUITING Phase EARLY_PHASE1
NCT04541875 Medication Adherence and Non-adherence in Adults With Rare Disease Status WITHDRAWN Phase N/A
NCT04535843 Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China Status RECRUITING Phase N/A
NCT04346888 A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients Status COMPLETED Phase PHASE2
NCT04226170 Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis Status TERMINATED Phase PHASE2
NCT04224506 A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis Status WITHDRAWN Phase N/A